Nanomedicine – MEDLINE-indexed journal on advances in medical nanoscale-structured material and devices

Nanomedicine (Impact factor: 5.413 (2014) is a uniquely medicine-focused journal, addressing the important challenges and advances in medical nanoscale-structured material and devices, biotechnology devices and molecular machine systems and nanorobotics, delivering this essential information in concise, clear and attractive article formats. The journal is a valuable information source for all players in the field – academic, industrial and clinical researchers, pharmaceutical and biotechnology companies, regulatory authorities and others across the scientific community.

Coverage includes:

  • Principles of nanomedicine, including basic research and theoretical applications
  • Nanotechnological advances and their potential medical applications
  • Disorders/conditions and the benefits of nanomedical tools versus traditional techniques
  • Pre-clinical testing of novel nanomedical tools
  • Diagnostic tools and applications
  • Implanted nanodevices for the prevention and treatment of disease and the alleviation of pain
  • Nanomedical tools in gene therapy for inherited diseases
  • Tissue, cell and genetic engineering involving nanomedical tools
  • Therapeutic applications of nanotechnology
  • Drug delivery using nano-particles (natural and artificial) or devices
  • Technologies already in clinical use: diagnostics, therapeutics or surgical aids
  • Prediction of adverse reactions of nanomedical technology, toxicology and safety issues
  • Ethical, regulatory and legal issues
  • Commercialization, funding and economics of nanomedical technology

Key Information

Indexing: Biotechnology Citation Index®, Chemical Abstracts, Current Contents®/Life Sciences, EMBASE/Excerpta Medica, Inspec®
Journal Citation Reports/Science Edition, MEDLINE/Index Medicus, Science Citation Index Expanded (SciSearch®), Scopus
Current Volume: Volume 11 (2016)
Issues per Year: 24
Average Abstract Views: 32,383 (January 2015 – December 2015)
Open Access Option: Yes
Average Lead Time to Online Publication: 14 – 16 weeks
Rapid Publication Option: Yes (6 weeks from submission to online publication)

Website: www.futuremedicine.com/loi/nnm